Shockwave acquisition propels J&J to lead in heart device industry with $13.1 billion investment
Johnson & Johnson (J&J) has made a significant move to strengthen its heart device business with a $13.1 billion deal to acquire Shockwave Medical. This acquisition is expected to propel J&J to the forefront of the cardiovascular market, diversifying its portfolio and boosting its competitiveness.
